🔎 Trials Near Me

ホーム › 大腸癌 › ニューヨーク › Queens

Queens、NYにおける大腸癌の臨床試験

Queensとその周辺地域(約30マイル以内)の拠点で、大腸癌に関する31件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

被験者募集中
  • Jamaica Hospital Medical Center (Data Collection Only), Richmond Hill · 1マイル先
  • Queens Cancer Center of Queens Hospital, Jamaica · 2マイル先
18歳以上 · 全性別 · 2026/10/05更新 · NCT04751435

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

被験者募集中第3相
  • Northwell Health Center for Advanced Medicine. /ID# 279590, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/10/02更新 · NCT07525206

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

被験者募集中第1相
  • START New York Long Island LLC, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

被験者募集中第2相
  • Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills · 3マイル先
  • Queens Cancer Center, Rego Park · 3マイル先
  • The New York Hospital Medical Center of Queens, Flushing · 6マイル先
  • 他2件
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎
  • Queens Hospital Center, Jamaica · 2マイル先
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

被験者募集中第3相
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9マイル先
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27マイル先
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

被験者募集中第1/2相
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/25更新 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

被験者募集中第3相
  • Perlmutter Cancer Center at NYU Long Island, Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

被験者募集中第1相
  • GSK Investigational Site, New Hyde Park · 9マイル先
18歳以上 · 全性別 · 2026/09/25更新 · NCT07277270

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

被験者募集中第3相
  • Perlmutter Cancer Center at NYU Long Island, Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

被験者募集中第3相
  • Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

被験者募集中第2/3相
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9マイル先
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

被験者募集中第2相
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07227636

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

被験者募集中第1/2相
  • Northwell Health / RJ Zuckerberg Cancer Center, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

被験者募集中第1相
  • New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9マイル先
18歳以上 · 全性別 · 2026/09/11更新 · NCT04929223

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

被験者募集中第3相
  • Clinical Study Site, Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

被験者募集中第1相
  • NYU Langone Health - Long Island, Mineola · 11マイル先
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472

A Study of MGC026 in Participants With Advanced Solid Tumors

被験者募集中第1相
  • START-New York Long Island, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

被験者募集中第1/2相
  • Clinical Research Alliance, Inc, Westbury · 14マイル先
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

被験者募集中第1/2相
  • Northwell Health Cancer Institute, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

被験者募集中第3相
  • MSK Nassau, Uniondale · 13マイル先
18歳以上 · 全性別 · 2026/07/22更新 · NCT05253651

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

被験者募集中第1相
  • START New York, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

被験者募集中第1相
  • START New York Long Island, LLC, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

被験者募集中第1相
  • START New York Long Island, LLC, Lake Success · 9マイル先
18歳〜99歳 · 全性別 · 2026/06/16更新 · NCT07540572

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

被験者募集中
  • VA New York Harbor Healthcare System - St. Albans Community Living Center, Jamaica · 2マイル先
18歳以上 · 全性別 · 2026/06/03更新 · NCT06559059

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

被験者募集中観察研究
  • Memorial Sloan Kettering Nassau, Rockville Centre · 10マイル先
18歳〜50歳 · 全性別 · 2026/04/07更新 · NCT04812912

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

被験者募集中観察研究
  • Queens Hospital Center, Jamaica · 2マイル先
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

被験者募集中第2相
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10マイル先
18歳以上 · 全性別 · 2026/02/18更新 · NCT06130280

Collection of Information to Better Understand Young Onset Colorectal Cancer

被験者募集中観察研究
  • Memorial Sloan Kettering Nassau, Rockville Centre · 10マイル先
18歳以上 · 全性別 · 2026/02/06更新 · NCT04489238

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

被験者募集中観察研究
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431

他の都市における大腸癌の試験

Queensにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。